Important for babies born during or outside of RSV season, this reminder alerts you when RSV season is starting.
Children should not receive SYNAGIS if they have ever had a severe allergic reaction to it. Signs and symptoms of a severe allergic reaction could include itchy rash; swelling of the face; difficulty swallowing; difficulty breathing; bluish color of the skin; muscle weakness or floppiness; and/or unresponsiveness. If your child has any of these signs or symptoms of a severe allergic reaction after getting SYNAGIS, call your child's healthcare provider or get medical help right away.
Sent via email, standard mail, or text message 2 weeks prior to your baby's next dosing appointment for SYNAGIS, these reminders will prompt you to confirm that appointment. It is important to keep your profile up to date as reminders are based on your baby's next appointment date for SYNAGIS as well as your region's RSV season.
When the RSV season ends, you'll receive this reminder as well as a request to complete our survey. Your valuable feedback will help us improve our program and continue to help parents just like you.
Depending on your baby’s diagnosis and age, he or she could still be at high risk for severe RSV disease for their second RSV season. A customized message will be sent to remind you to contact your baby’s doctor for more information.
You may be wondering, why does my high-risk baby need multiple doses of SYNAGIS? It’s because SYNAGIS is not a vaccine. Instead, it’s an injection of antibodies that is given monthly to help protect high-risk babies from severe RSV disease. Like the flu, RSV is seasonal. Your baby is more likely to catch the virus during certain times of the year.
The first injection of SYNAGIS should be given before the RSV season starts and continues on a schedule of 1 injection every 28 to 30 days. The reminders can help you stay on track so that your baby gets every injection on time during the entire RSV season.
Wondering when RSV season starts where you live? Ask your doctor or click here.
Children should not receive SYNAGIS if they have ever had a severe allergic reaction to it. Signs and symptoms of a severe allergic reaction could include itchy rash; swelling of the face; difficulty swallowing; difficulty breathing; bluish color of the skin; muscle weakness or floppiness; and/or unresponsiveness. If your child has any of these signs or symptoms of a severe allergic reaction after getting SYNAGIS, call your child’s healthcare provider or get medical help right away.
SYNAGIS is given as a monthly injection, usually in the thigh (leg) muscle, by your child’s healthcare provider. If your child has a problem with bleeding or bruises easily, an injection could cause a problem. Your child should receive their first injection of SYNAGIS before the RSV season starts, to help protect them before RSV becomes active. RSV season is usually fall through spring, but it may begin earlier or last longer in certain areas. When RSV is most active, your child will need to receive injections of SYNAGIS every 28-30 days to help protect them from severe RSV disease for about a month. Your child should continue to receive monthly injections of SYNAGIS until the end of RSV season. Your child may still get severe RSV disease after receiving SYNAGIS. If your child has an RSV infection, they should continue to get their monthly injections throughout the RSV season to help prevent severe disease from new RSV infections.
The effectiveness of injections of SYNAGIS given less than monthly throughout the RSV season has not been established.
Serious side effects include severe allergic reactions, which may happen after any injection of SYNAGIS and may be life-threatening or cause death. Call your child’s healthcare provider or get medical help right away if your child has any of the signs or symptoms of a serious allergic reaction. See “Who should not receive SYNAGIS?” for more information.
Common side effects of SYNAGIS include fever and rash.
These are not all the possible side effects of SYNAGIS.
SYNAGIS is a prescription medication that is used to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in children:
It is not known if SYNAGIS is safe and effective: